|
|
Line 812: |
Line 812: |
| | | |
| | | |
− | <h3>The docking simulation of “Thioredoxin-Fusion protein”</h3>
| + | |
− | <p>1. Since the structure of Thioredoxin has been studied, we can lock down the active site of thioredoxin by use Uniprot. The team found that there are two active site , which are NO. 33 and NO.36 of the sequence.</p>
| + | |
− | <p>2. By using NCBI BLAST, the team compared the sequence of the fusion protein with Thioredoxin. The team confirmed that the active sites of fusion protein corresponding to the ones of Thioredoxin are No.33 and 36 , both are Cysteine, C.<br><br></p>
| + | |
− | <img src="https://static.igem.org/mediawiki/2017/7/72/T--CSMU_NCHU_Taiwan--m-4-thioredoxin.png" style="width: 100%">
| + | |
− | <br><br>
| + | |
− | <p>3. The team later constructed a fusion protein 3D model and then labelled the active sites by using PyMOL. By creating the model, the team could learn why thioredoxin is helpful toward protein folding since the active sites of Thioredoxin are not facing away from MSMEG5998.<br><br></p>
| + | |
− | <img src="https://static.igem.org/mediawiki/2017/7/7e/T--CSMU_NCHU_Taiwan--model08.png" style="width: 100%">
| + | |
− | <br><br>
| + | |
− | <p>This 3D model shows the surface of the fusion protein, which allows us to grasp the concept of what our protein looks like. The region labeled in red is the possible binding site of Thioredoxin, which maybe can assist the fusion protein itself or other proteins folding.<br></p>
| + | |
− | <h3>The structure of the fusion protein (MSMEG5998 part)</h3>
| + | |
− | <p>1. While the structure of MSMEG5998 remains unknown, the team still manage to predict the model by using similar protein to create a model, the software tool we used is Swiss Model<small><small>[3] [4]</small></small>.</p>
| + | |
− | <p>2. When deciding the model of MEMEG5998, the team used the Swiss Model by comparing the amino acid sequence among the database of protein sequence. There are two main factors lead to two different models, which are by coverage or by identity. The team choose the highest coverage protein sequence to be our model, named” MSMEG5998 Swiss model”.<br><br></p>
| + | |
− | <img src="https://static.igem.org/mediawiki/2017/b/b1/T--CSMU_NCHU_Taiwan--model09.png" style="width: 60%" class="center">
| + | |
− | <img src="https://static.igem.org/mediawiki/2017/0/02/T--CSMU_NCHU_Taiwan--swiss.png" style="width: 100%"> | + | |
− | <br><br>
| + | |
− | <p>3. The sequence of the MSMEG5998 by using Swiss model is compared with that of fusion protein by using Uniprot. The team then discovered three similar groups being labeled below, which are likely active sites.<br><br></p>
| + | |
− | <img src="https://static.igem.org/mediawiki/2017/0/02/T--CSMU_NCHU_Taiwan--m-8-uniprot.png" style="width: 100%">
| + | |
− | <br><br>
| + | |
− | <p>4. The three possible loci corresponding to the fusion protein sequence are:</p>
| + | |
− | <p>i. 189,Arginine,R</p>
| + | |
− | <p>ii. 214,Glutamine,Q</p>
| + | |
− | <p>iii. 246,Alanine,A</p>
| + | |
− | <p>Since the pdb. files presented by raptorX were unable to visualize hydrogen bonds of the compound, thus the team used PMViewer v1.5.7 to add on hydrogen bonds and negative charge. (the following pictures are compounds before and after enhancements)<br><br></p>
| + | |
− | <h3>Further enhancements to the compound before docking simulation on MSMEG5998</h3>
| + | |
− | <img src="https://static.igem.org/mediawiki/2017/7/79/T--CSMU_NCHU_Taiwan--model121.png" style="width: 100%">
| + | |
− | <p><br>Under PMViewer, the appearance of the protein before enhancements.<br><br></p>
| + | |
− | | + | |
− | <img src="https://static.igem.org/mediawiki/2017/9/9d/T--CSMU_NCHU_Taiwan--model131.png" style="width: 100%">
| + | |
− | <p><br>The fusion protein after enhancements, which adds hydrogen and charge to the protein. This process allows the structure and the binding process as real as possible.<br></p>
| + | |
− | | + | |
− | | + | |
− | | + | |
− | <h3>Adding ligand to the docking simulation of MSMEG5998-Aflatoxin B2</h3>
| + | |
− | <p>Search PubChem to locate the ligand, which in this case is AflatoxinB2, and then download the SDF format.<br></p>
| + | |
− | <img src="https://static.igem.org/mediawiki/2017/1/1c/T--CSMU_NCHU_Taiwan--m-11-aflatoxin-3.png" style="width: 100%">
| + | |
− | | + | |
− | <br><br>
| + | |
− | <h3>The docking of MSMEG5998 to Aflatoxin B2</h3>
| + | |
− | | + | |
− | <p>1. The settings for Aflatoxin B2 before docking:
| + | |
− | Minimize the energy, in order to acquire a stabilized compound which is easier to go through the docking simulation.
| + | |
− | </p>
| + | |
− | <img src="https://static.igem.org/mediawiki/2017/4/4e/T--CSMU_NCHU_Taiwan--model15.png" style="width: 100%">
| + | |
− | <p><br>2. Select the docking function to proceed.</p>
| + | |
− | <h3>Autodocking area</h3>
| + | |
− | <p>The possible autodocking area are limited to the three active sites of MSMEG5998 mentioned earlier, which can increase the model’s accuracy. After autodocking, we visualize the result by using PyMOL to create a 3D docking model. The three active sites for docking are tested, and compared to one another. The team finally come up with one ideal active site, which is 214,glutamine,Q.<br></p>
| + | |
− | | + | |
− | <img src="https://static.igem.org/mediawiki/2017/1/17/T--CSMU_NCHU_Taiwan--model16.png" style="width: 100%">
| + | |
− | <p><br>The docking was processed by Autodock (please visit our <a href="https://2017.igem.org/Team:CSMU_NCHU_Taiwan/Software" target="_blank">software tools page</a>, the cube area is the area our team choose to process the docking stimulation, the results are in the picture below.<br></p>
| + | |
− | <img src="https://static.igem.org/mediawiki/2017/c/c9/T--CSMU_NCHU_Taiwan--m-12-214-2.png" style="width: 100%">
| + | |
− | <p><br><br>This is a side view of the protein macromolecule. The MSMEG5998 active site 214 is presented in red, while the blue compound represents Aflatoxin.<br><br></p>
| + | |
− | | + | |
− | </div>
| + | |
− | <div id="model-conslusion" class="m-block" >
| + | |
− | <h2 class="m-subtitle">Discussion and Conclusion</h2>
| + | |
− | <img src="https://static.igem.org/mediawiki/2017/f/f8/T--CSMU_NCHU_Taiwan--green.png" style="width: 60%; transform: translate(35%, -150%);">
| + | |
− | | + | |
− | <p>1. By using protein modeling techniques, the team predicted a fusion protein with multifunction while one doesn’t inhibit the other, or creating structural failure. Which later on helped us in the wet lab experiment to proceed.<br></p>
| + | |
− | <p>2. With the software tools, the team is able to predict an enhanced fusion protein (MSMEG5998 combined with Thioredoxin) that performs better than the original protein (MSMEG5998).<br></p>
| + | |
− | <p>3. With the cooperation of the wet lab projects, the team is able to confirm the results of the prediction.(Click the button to visit our project’s result.)</p>
| + | |
− | <a href="https://2017.igem.org/Team:CSMU_NCHU_Taiwan/Results#antidote" target="_blank">
| + | |
− | <img class="right" src="https://static.igem.org/mediawiki/2017/6/66/T--CSMU_NCHU_Taiwan--see_more.png" style="width: 15%" alt=""></a><br>
| + | |
− | <p>4. Future goals:</p>
| + | |
− | | + | |
− | <p>i. unfortunately, there is a time limit to our project. However, the team would like to continue our modeling project and also put the theory into practice, trying to see whether active site 214 is the actually binding site with Aflatoxin. The team would conduct experiments of point mutation on site 214, to see if the binding affinity changes or not, in order to explain why this site 214 is crucial toward Aflatoxin degradation.</p>
| + | |
− | <p>ii. After conducting the two main modeling project, our team successfully predicts the function of our fusion protein; however, the long term goal is that the team envisions our aflatoxin-degrading protein put in to massive and commercialized production. <font color="#1c869c"> Therefore, our team would want to measure the productivity of our protein, in order to seek for the ideal producing conditions and reach the maximum efficiency.</font>(Click the button to see some of the results from the experiment our team has conducted.)<br></p>
| + | |
− | <a href="https://2017.igem.org/Team:CSMU_NCHU_Taiwan/Model/Parts" target="_blank">
| + | |
− | <img class="right" src="https://static.igem.org/mediawiki/2017/6/66/T--CSMU_NCHU_Taiwan--see_more.png" style="width: 15%" alt=""></a>
| + | |
− | <br>
| + | |
− | | + | |
− | | + | |
− | </div>
| + | |
− | <div id="model-references" class="m-block" >
| + | |
− | <h2 class="m-subtitle">References</h2>
| + | |
| <img src="https://static.igem.org/mediawiki/2017/f/f8/T--CSMU_NCHU_Taiwan--green.png" style="width: 60%; transform: translate(35%, -150%);"> | | <img src="https://static.igem.org/mediawiki/2017/f/f8/T--CSMU_NCHU_Taiwan--green.png" style="width: 60%; transform: translate(35%, -150%);"> |
| | | |